A Phase I, Single-center, Randomized Double-blind, Placebo-controlled, Single & Multiple Ascending Dose Study to Assess the Tolerability and Pharmacokinetics of HEC74647PA Capsule in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Apr 2019
Price : $35 *
At a glance
- Drugs HEC 74647PA (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sunshine Lake Pharma
- 08 Apr 2019 Planned End Date changed from 24 Dec 2018 to 31 Jan 2020.
- 08 Apr 2019 Planned primary completion date changed from 24 Dec 2018 to 1 Jul 2019.
- 25 Sep 2018 New trial record